454 related articles for article (PubMed ID: 21674414)
1. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Lynch JP; Tazelaar H
Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
[TBL] [Abstract][Full Text] [Related]
2. Wegener's granulomatosis: evolving concepts in treatment.
Lynch JP; White E; Tazelaar H; Langford CA
Semin Respir Crit Care Med; 2004 Oct; 25(5):491-521. PubMed ID: 16088495
[TBL] [Abstract][Full Text] [Related]
3. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
[TBL] [Abstract][Full Text] [Related]
4. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
Wang T; Weigt SS; Belperio JA; Lynch JP
Semin Respir Crit Care Med; 2011 Jun; 32(3):346-70. PubMed ID: 21674420
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
10. Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.
Cadoni G; Prelajade D; Campobasso E; Calŏ L; Agostino S; Manna R; Paludetti G
Acta Otolaryngol; 2005 Oct; 125(10):1105-10. PubMed ID: 16298794
[TBL] [Abstract][Full Text] [Related]
11. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
Reinhold-Keller E; Tatsis E; Gross WL
Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
[TBL] [Abstract][Full Text] [Related]
12. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
[TBL] [Abstract][Full Text] [Related]
13. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
Villa-Forte A; Clark TM; Gomes M; Carey J; Mascha E; Karafa MT; Roberson G; Langford CA; Hoffman GS
Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes of ANCA-associated renal vasculitis.
Seck SM; Dussol B; Brunet P; Burtey S
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
[TBL] [Abstract][Full Text] [Related]
16. [Wegener's granulomatosis: diagnosis and treatment].
Vera-Lastra O; Olvera-Acevedo A; McDonal-Vera A; Pacheco-Ruelas M; Gayosso-Rivera JA
Gac Med Mex; 2009; 145(2):121-9. PubMed ID: 19518019
[TBL] [Abstract][Full Text] [Related]
17. [Severe Wegener's granulomatosis successfully treated with rituximab].
Semenkova EN; Krivosheev OG; Novikov PI; Osipenko VI; Nosova NR; Parfenova SA; Nikiforova NV; Borodin OO
Ter Arkh; 2010; 82(6):53-5. PubMed ID: 20731113
[TBL] [Abstract][Full Text] [Related]
18. Primary systemic vasculitis.
Day C; Savage C
Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
[TBL] [Abstract][Full Text] [Related]
19. Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide.
Benucci M; Li Gobbi F; Panconesi P; Manfredi M; Sarzi-Puttini P; Atzeni F
Reumatismo; 2013 May; 65(2):90-4. PubMed ID: 23877415
[TBL] [Abstract][Full Text] [Related]
20. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Reinhold-Keller E
Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
